Can Croton lechleri help reduce or eliminate uterine fibroids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Croton Lechleri Does Not Reduce or Eliminate Uterine Fibroids

There is no scientific evidence supporting the use of Croton lechleri (also known as Dragon's Blood or Sangre de Drago) for reducing or eliminating uterine fibroids. Based on current medical guidelines, Croton lechleri is not recognized as an effective treatment for uterine fibroids 1.

Evidence-Based Treatments for Uterine Fibroids

Uterine fibroids are common benign neoplasms affecting up to 80% of women by age 50, with higher prevalence in Black women 1. Treatment should be guided by:

  1. Symptom severity
  2. Fibroid location and size
  3. Patient's fertility desires
  4. Impact on quality of life

Medical Management Options

For patients with symptomatic fibroids who wish to avoid surgery, the following evidence-based treatments are available:

  • First-line medical management:

    • NSAIDs and estrogen-progestin oral contraceptive pills for bleeding control 1
    • Tranexamic acid (nonhormonal option) for reducing bleeding symptoms 1
    • Progestin-containing intrauterine devices 1
  • Second-line medical management:

    • GnRH agonists (leuprolide acetate) and antagonists (elagolix, linzagolix, relugolix) - can reduce bleeding and significantly decrease fibroid volume by 40-80% 1
    • Progesterone receptor modulators (ulipristal acetate) - reduce both bleeding and bulk symptoms 1
      • Note: Ulipristal acetate has shown efficacy but has hepatotoxicity concerns in the US 1

Procedural/Surgical Options

For patients requiring more definitive treatment:

  • Minimally invasive procedures:

    • Hysteroscopic myomectomy - procedure of choice for pedunculated submucosal fibroids <5cm 1
    • Uterine artery embolization (UAE) - reduces uterine volume by 40-50% with 80% symptomatic control 1
    • MR-guided focused ultrasound (MRgFUS) - can decrease fibroid diameter by 18-30% 1
  • Definitive surgical treatment:

    • Myomectomy (hysteroscopic, laparoscopic, or open) - for women desiring fertility preservation 1
    • Hysterectomy - definitive treatment, accounting for 75% of fibroid treatments in the US 1

Important Considerations

  1. Natural history: Fibroids typically shrink after menopause due to decreased estrogen 1

  2. Fertility impact: Treatment choice should consider future fertility desires, as some treatments may affect reproductive outcomes 1

  3. Recurrence risk: Medical treatments typically provide temporary relief, with symptoms recurring after cessation 1

  4. Pitfalls to avoid:

    • Delaying appropriate treatment while pursuing unproven remedies may lead to worsening symptoms, anemia, and reduced quality of life
    • Assuming all natural products are safe - even if Croton lechleri had any effect (which is not supported by evidence), natural products can have side effects and drug interactions

Conclusion

When seeking treatment for uterine fibroids, patients should pursue evidence-based options under medical supervision rather than unproven remedies like Croton lechleri. The most appropriate treatment depends on symptom severity, fibroid characteristics, and reproductive goals, with options ranging from hormonal medications to minimally invasive procedures to definitive surgery.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.